188 related articles for article (PubMed ID: 24418837)
1. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine.
Spicer JO; Thomas S; Holst A; Baughman W; Farley MM
Pediatr Infect Dis J; 2014 Feb; 33(2):158-64. PubMed ID: 24418837
[TBL] [Abstract][Full Text] [Related]
2. Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ ethnicity in Connecticut, 1998-2008.
Soto K; Petit S; Hadler JL
Public Health Rep; 2011; 126 Suppl 3(Suppl 3):81-8. PubMed ID: 21836741
[TBL] [Abstract][Full Text] [Related]
3. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.
Flannery B; Schrag S; Bennett NM; Lynfield R; Harrison LH; Reingold A; Cieslak PR; Hadler J; Farley MM; Facklam RR; Zell ER; Whitney CG;
JAMA; 2004 May; 291(18):2197-203. PubMed ID: 15138241
[TBL] [Abstract][Full Text] [Related]
4. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.
Hsu K; Pelton S; Karumuri S; Heisey-Grove D; Klein J;
Pediatr Infect Dis J; 2005 Jan; 24(1):17-23. PubMed ID: 15665705
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
6. Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era.
de St Maurice A; Schaffner W; Griffin MR; Halasa N; Grijalva CG
J Infect Dis; 2016 Sep; 214(5):792-7. PubMed ID: 27247342
[TBL] [Abstract][Full Text] [Related]
7. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.
Feikin DR; Kagucia EW; Loo JD; Link-Gelles R; Puhan MA; Cherian T; Levine OS; Whitney CG; O'Brien KL; Moore MR;
PLoS Med; 2013; 10(9):e1001517. PubMed ID: 24086113
[TBL] [Abstract][Full Text] [Related]
8. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
[TBL] [Abstract][Full Text] [Related]
9. A surveillance system of Invasive Pneumococcal Disease in North-Eastern Italy.
Baldovin T; Lazzari R; Russo F; Bertoncello C; Buja A; Furlan P; Cocchio S; Palù G; Baldo V
Ann Ig; 2016; 28(1):15-24. PubMed ID: 26980506
[TBL] [Abstract][Full Text] [Related]
10. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
11. Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.
Payne AB; Link-Gelles R; Azonobi I; Hooper WC; Beall BW; Jorgensen JH; Juni B; Moore M;
Pediatr Infect Dis J; 2013 Dec; 32(12):1308-12. PubMed ID: 23811745
[TBL] [Abstract][Full Text] [Related]
12. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
13. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine.
Talbot TR; Poehling KA; Hartert TV; Arbogast PG; Halasa NB; Mitchel E; Schaffner W; Craig AS; Edwards KM; Griffin MR
Pediatr Infect Dis J; 2004 Aug; 23(8):726-31. PubMed ID: 15295222
[TBL] [Abstract][Full Text] [Related]
14. Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.
Moore CE; Paul J; Foster D; Mahar SA; Griffiths D; Knox K; Peto TE; Walker AS; Crook DW;
J Infect Dis; 2014 Oct; 210(7):1001-11. PubMed ID: 24719477
[TBL] [Abstract][Full Text] [Related]
15. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
Jayasinghe S; Chiu C; Menzies R; Lehmann D; Cook H; Giele C; Krause V; McIntyre P
Vaccine; 2015 Nov; 33(48):6666-74. PubMed ID: 26519550
[TBL] [Abstract][Full Text] [Related]
17. Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota.
Tsigrelis C; Tleyjeh IM; Huskins WC; Lahr BD; Nyre LM; Virk A; Baddour LM
Mayo Clin Proc; 2009 Oct; 84(10):871-5. PubMed ID: 19797776
[TBL] [Abstract][Full Text] [Related]
18. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
[TBL] [Abstract][Full Text] [Related]
19. Marked Reduction of Socioeconomic and Racial Disparities in Invasive Pneumococcal Disease Associated With Conjugate Pneumococcal Vaccines.
Raman R; Brennan J; Ndi D; Sloan C; Markus TM; Schaffner W; Talbot HK
J Infect Dis; 2021 Apr; 223(7):1250-1259. PubMed ID: 32780860
[TBL] [Abstract][Full Text] [Related]
20. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.
Ben-Shimol S; Greenberg D; Givon-Lavi N; Schlesinger Y; Somekh E; Aviner S; Miron D; Dagan R
Vaccine; 2014 Jun; 32(27):3452-9. PubMed ID: 24690148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
